跳至主要内容
临床试验/NCT04957992
NCT04957992已完成不适用

Infant Formula and Toddler Drink Feeding Intervention Through 24 Months of Age

Abbott Nutrition84 个研究点 分布在 1 个国家目标入组 607 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
607
试验地点
84
主要终点
Growth

研究概览

简要总结

The purpose of this study is to evaluate the growth and development outcomes of infants fed a new infant formula and toddler drink through 24 months of age.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
0 Days 至 14 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Participant is judged to be in good health as determined from participant's medical history
  • Participant is a singleton from a full-term birth with a gestational age of 37 - 42 weeks by parent report
  • Participant's birth weight was ≥ 2490 g (~5 lbs. 8 oz.)
  • Parent(s) confirm their intention to feed their infant the study product as the sole source of feeding from Study Visit 1 to 6 months of age, and as the sole milk beverage during the first 12 months of life
  • Parent(s) confirm their intention to feed the infant the assigned toddler drink from 12 months of life to 24 months of life as the primary milk beverage
  • Parent(s) confirm their intention not to administer vitamin or mineral supplements,(except for vitamin D supplements if instructed by their healthcare professional) from enrollment through the duration of the study
  • Parent(s) confirm their intention not to administer solid foods or juices to the infant from enrollment through 6 months of age unless recommended by the participant's HCP
  • Participant's parent(s) has voluntarily signed and dated an informed consent form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided Health Insurance Portability and Accountability Act (HIPAA) (or other applicable privacy regulation) authorization prior to any participation in the study
  • If parent(s) elect to feed the participant human milk, they confirm that their infant was fed human milk since birth and confirm their intention to exclusively feed human milk as the sole source of feeding through 6 months of age.
  • If parent(s) of human milk fed participant elect to supplement or wean, they confirm their intention to use the experimental supplemental/weaning formula and experimental toddler drink as the primary milk beverage.

排除标准

  • An adverse maternal, fetal or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development
  • Awareness of a positive drug screen (including but not limited to cocaine, heroin, or methamphetamine) in the mother or participant
  • Suspected maternal substance abuse including alcohol
  • Participant is taking and plans to continue medications (including over the counter (OTC), such as Mylicon® for gas), home remedies (such as juice for constipation), herbal preparations, prebiotics or probiotics, or rehydration fluids that might affect GI tolerance
  • Participant is in another study that has not been approved as a concomitant study by AN
  • Participant has been treated with antibiotics (except for topical antibiotics, eye drops) prior to enrollment
  • Participant has been treated with other medications (besides antibiotics) that in the opinion of the PI may affect growth, GI tolerance and/or development, prior to enrollment

结局指标

主要结局

Growth

时间窗: Study Day 1 to 6 Months of Age

weight for age z-score

次要结局

  • Length(Study Day 1 to 24 Months of Age)
  • Incidence of respiratory infection between study groups(Study Day 1 to 24 Months of Age)
  • Number of respiratory infection episodes between study groups(Study Day 1 to 24 Months of Age)
  • Incidence of infection morbidity between study groups(Study Day 1 to 24 Months of Age)
  • Number of episodes of infection morbidity between study groups(Study Day 1 to 24 Months of Age)
  • Weight(Study Day 1 to 24 Months of Age)
  • Head Circumference(Study Day 1 to 24 Months of Age)
  • Gastrointestinal Tolerance(Study Day 1 to 12 months of Age)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (84)

Loading locations...

相似试验